PMEF
TSVT

Point72 Middle East FZE’s 2seventy bio TSVT Stock Holding History

Point72 Middle East FZE’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,832
Closed -$82.8K – 2214
2022
Q4 		$82.8K Buy
+8,832
New +$125K ﹤0.01% 1328

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Middle East FZE's TSVT Position: Q1 2023 in Review

Point72 Middle East FZE sold out of 2seventy bio (TSVT) in Q1 2023, closing a stake of 8,832 shares — an estimated $82.8K sold.

Point72 Middle East FZE first reported a position in TSVT in Q4 2022 and held it in 1 quarter. The position peaked at $82.8K in Q4 2022. 146 funds tracked by Wall St. Rank hold TSVT as of Q1 2023.

  • Point72 Middle East FZE reported no remaining 2seventy bio position as of Q1 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 8,832 2seventy bio shares in Q1 2023, an estimated $82.8K.
  • Point72 Middle East FZE first reported a position in 2seventy bio in Q4 2022 and held it in 1 quarter.
  • Point72 Middle East FZE's 2seventy bio position peaked at $82.8K in Q4 2022.
  • 146 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2023.

Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.